A new drug for targeted therapy of cutaneous T-cell lymphoma—mogamulizumab

doi:10.3969/j.issn.1672-3384.2019.07.002

PDF(892 KB)

Clinical Medication Journal ›› 2019, Vol. 17 ›› Issue (7) : 4-7. DOI: 10.3969/j.issn.1672-3384.2019.07.002

A new drug for targeted therapy of cutaneous T-cell lymphoma—mogamulizumab

{{article.zuoZhe_EN}}

Author information +

History +

HeighLight

Abstract

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2019, 17(7): 4-7 https://doi.org/10.3969/j.issn.1672-3384.2019.07.002

References

List( Publishing order | Descend order by publishing year | Descend order by cited within ) Chart analysis

References

Funding

RIGHTS & PERMISSIONS

PDF(892 KB)

Accesses

Citation

Detail

Sections

Recommended

Received	Published
2019-04-26	2019-07-31
Issue Date
2019-07-31

Please choose a citation manager

Content to export